(MDGL) Madrigal - Performance 36.9% in 12m
Compare MDGL with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
73.27%
#5 in Group
Rel. Strength
85.90%
#1078 in Universe
Total Return 12m
36.85%
#30 in Group
Total Return 5y
408.59%
#7 in Group
P/E -
(unknown) Percentile in Group
P/E Forward -
(unknown) Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield -6.79%
(unknown) Percentile in Group
12m Total Return: MDGL (36.9%) vs XBI (-11%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: MDGL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MDGL
Total Return (including Dividends) | MDGL | XBI | S&P 500 |
---|---|---|---|
1 Month | 6.74% | -5.85% | -3.01% |
3 Months | 6.64% | -11.95% | -3.15% |
12 Months | 36.85% | -11.00% | 10.19% |
5 Years | 408.59% | 0.65% | 129.24% |
Trend Score (consistency of price movement) | MDGL | XBI | S&P 500 |
1 Month | -7.30% | -59.8% | -5.5% |
3 Months | 46.4% | -70.5% | -58.4% |
12 Months | 71.7% | -6.9% | 84.1% |
5 Years | 65.2% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #33 | 13.4% | 10.1% |
3 Month | #30 | 21.1% | 10.1% |
12 Month | #29 | 53.8% | 24.2% |
5 Years | #7 | 405% | 122% |
FAQs
Does MDGL Madrigal outperforms the market?
Yes,
over the last 12 months MDGL made 36.85%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months MDGL made 6.64%, while XBI made -11.95%.
Over the last 3 months MDGL made 6.64%, while XBI made -11.95%.
Performance Comparison MDGL vs Indeces and Sectors
MDGL vs. Indices MDGL is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 0.95% | 9.75% | 60.1% | 26.7% |
US NASDAQ 100 | QQQ | 1.93% | 10.8% | 60.9% | 28.3% |
US Dow Jones Industrial 30 | DIA | 0.75% | 8.88% | 59.2% | 27.3% |
German DAX 40 | DAX | 2.25% | 10.1% | 43.3% | 15.2% |
Shanghai Shenzhen CSI 300 | CSI 300 | 1.24% | 6.51% | 75.3% | 27.7% |
Hongkong Hang Seng | HSI | -1.02% | 3.97% | 69.3% | 19.5% |
India NIFTY 50 | INDA | -0.08% | -1.13% | 70.5% | 36.2% |
Brasil Bovespa | EWZ | 0.84% | -1.55% | 68.1% | 48.6% |
MDGL vs. Sectors MDGL is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 2.49% | 10.6% | 52.0% | 17.6% |
Consumer Discretionary | XLY | 0.19% | 10.6% | 56.8% | 22.8% |
Consumer Staples | XLP | -1.84% | 8.58% | 59.3% | 25.8% |
Energy | XLE | -0.14% | -1.28% | 54.5% | 36.0% |
Financial | XLF | 0.47% | 9.44% | 48.0% | 14.6% |
Health Care | XLV | 0.53% | 9.90% | 64.8% | 35.2% |
Industrial | XLI | 0.64% | 7.43% | 60.8% | 28.3% |
Materials | XLB | -0.15% | 6.23% | 68.2% | 40.8% |
Real Estate | XLRE | -1.09% | 9.43% | 63.2% | 23.5% |
Technology | XLK | 2.08% | 10.8% | 65.2% | 34.8% |
Utilities | XLU | -2.34% | 5.92% | 61.0% | 11.6% |
Aerospace & Defense | XAR | 1.55% | 5.46% | 56.2% | 15.9% |
Biotech | XBI | 5.51% | 12.6% | 77.8% | 47.9% |
Homebuilder | XHB | 0.45% | 6.59% | 79.5% | 44.6% |
Retail | XRT | -1.35% | 7.24% | 64.2% | 41.6% |